Drug Targeting Tumor Metabolism Discovered by MD Anderson's Institute for Applied Cancer Science Enters Clinical Trial
Wednesday, October 26, 2016 - 16:01
in Health & Medicine
The University of Texas MD Anderson Cancer Center's Institute for Applied Cancer Science (IACS) has initiated the first clinical study of a novel drug designed to starve cancer cells, IACS-10759.